Reviewing our financial results announced last Friday, which garnered significant attention for their positive outcomes, I engaged in dynamic and informative sessions with analysts and investors in the morning, followed by similar discussions with the media in the afternoon.
All were keen to understand our financial performance and strategies for 2024, so I began by reviewing our recent outstanding results, which I would briefly recap here. In the financial year ended December 31, 2023, our revenue surpassed RM3 billion, a record-breaking achievement, with a PATAMI of RM281 million, marking a 57% increase.
We were also proud to announce a dividend increase of 68% to 3.35 sen per share. The robust demand and revenue intensity were crucial to our success in FY2023, and so is the dedication of Team KPJ and the continued trust from both patients and shareholders.
A significant focus of interest at the sessions was Health Tourism, and I outlined our plans to maximise its potential, including leveraging the admission of two of our hospitals - KPJ Damansara Specialist Hospital and Damansara Specialist Hospital 2 - into the Mayo Clinic Care Network.
Furthermore, I shared insights into our forthcoming initiatives, including our robotic program and the Academic Health System, aimed at creating additional value for our patients.
Despite the session being held four days post-results announcement, the level of engagement from attendees was highly encouraging. As a leader of a public listed company, I am committed to transparency and governance. Fostering open communication with our stakeholders is important to me.
Our share prices traded on Bursa Malaysia have demonstrated remarkable progress in recent months. I am grateful for the support we have received, and it serves as a strong motivation for both myself and Team KPJ to strive for even greater achievements in the months ahead.
#KPJHealthcare #CareForLife
International Regulatory Affairs
3yWell deserved Mr. Chin!